We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+38.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$680B
AUM Growth
+$89.5B
Cap. Flow
-$28.8B
Cap. Flow %
-4.24%
Top 10 Hldgs %
21.1%
Holding
2,615
New
56
Increased
1,632
Reduced
714
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 18.45%
2 Healthcare 18.09%
3 Consumer Discretionary 13.59%
4 Financials 13.39%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWRE icon
2501
Aware
AWRE
$26M
$43K ﹤0.01%
12,000
HOS
2502
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$39K ﹤0.01%
31,800
QHC
2503
DELISTED
Quorum Health Corporation
QHC
$38K ﹤0.01%
27,283
+100
+0.4% +$269
STRR
2504
DELISTED
Star Equity Holdings
STRR
$36K ﹤0.01%
792
ENZ
2505
DELISTED
Enzo Biochem, Inc.
ENZ
$36K ﹤0.01%
13,343
+100
+0.8% +$327
PHLT
2506
DELISTED
Performant Healthcare Inc
PHLT
$33K ﹤0.01%
15,900
ONCS
2507
DELISTED
OncoSec Medical Incorporated
ONCS
$32K ﹤0.01%
257
ASCMA
2508
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$32K ﹤0.01%
42,277
EFOI icon
2509
Energy Focus
EFOI
$19.2M
$29K ﹤0.01%
678
-33
-5% -$1.17K
FCEL icon
2510
FuelCell Energy
FCEL
$1.73B
$29K ﹤0.01%
332
CAW
2511
DELISTED
CCA Industries, Inc.
CAW
$29K ﹤0.01%
19,247
LYTS icon
2512
LSI Industries
LYTS
$890M
$27K ﹤0.01%
10,325
UPBD icon
2513
PUT
Upbound Group
UPBD
$1.11B
$27K ﹤0.01%
+1,300
New +$24K
ACGN
2514
DELISTED
Aceragen Inc
ACGN
$27K ﹤0.01%
615
SREV
2515
DELISTED
ServiceSource International, Inc.
SREV
$24K ﹤0.01%
26,198
-177,500
-87% -$186K
STRR
2516
Star Equity Holdings
STRR
$40.1M
$22K ﹤0.01%
1,460
MMAT
2517
DELISTED
Meta Materials Inc. Common Stock
MMAT
$21K ﹤0.01%
63
-29
-32% -$7.28K
ALTO icon
2518
Alto Ingredients
ALTO
$315M
$20K ﹤0.01%
20,000
SUMR
2519
DELISTED
Summer Infant, Inc.
SUMR
$18K ﹤0.01%
2,722
QUIK icon
2520
QuickLogic
QUIK
$238M
$11K ﹤0.01%
1,322
+579
+78% +$6.77K
AREX
2521
DELISTED
Approach Resources Inc.
AREX
$10K ﹤0.01%
29,005
CBK
2522
DELISTED
Christopher & Banks Corporation
CBK
$4K ﹤0.01%
12,512
ACIU icon
2523
AC Immune
ACIU
$267M
-378,700
Closed -$3.58M
ALB icon
2524
PUT
Albemarle
ALB
$15.1B
-4,500
Closed -$347K
BTI icon
2525
British American Tobacco
BTI
$120B
-9,111
Closed -$290K

Similar funds

T. Rowe Price Associates's Q1 2019 Portfolio in Review

As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates withdrew a net $28.8B in Q1 2019, closing 86 positions and reducing 714 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Fox Class B worth $420M.

  • T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
  • T. Rowe Price Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $25.3B.
  • T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
  • T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
  • T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.